In Brief: U.S./EU device MRA meeting
This article was originally published in The Gray Sheet
Executive SummaryU.S./EU device MRA meeting: Charles Ludolph of the U.S. Commerce Department's Office of European Affairs is among speakers slated for a June 18 conference on the implications of the U.S./EU mutual recognition agreement on medical devices, which negotiators completed on June 13. Joseph Levitt, deputy director for regulations and policy in FDA's Center for Devices & Radiological Health, and several industry executives are tentatively scheduled to participate in the discussion. The conference is sponsored by the Health Industry Manufactures Association and will be held at the J.W. Marriott Hotel in Washington, D.C. U.S. and EU officials likely will meet the week of June 16 to initial the pact...
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.